The association of a genetic variant in multi-drug resistance gene and colorectal cancer susceptibility
Gene Reports, ISSN: 2452-0144, Vol: 24, Page: 101252
2021
- 2Citations
- 5Captures
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Article Description
Colorectal cancer (CRC) is one of the most malignant tumors worldwide with poor prognosis. There are various genetic polymorphisms associated with colorectal cancer have been reported in recent studies. Here, we examined the relationship between the multidrug resistance mutation 1 (MDR1 or ATP-binding cassette sub-family B member 1, ABCB1) (rs1128503) polymorphism and the risk of CRC in 334 individuals with or without CRC. DNA was extracted and genotyped using a Taq-Man based PCR method. The MDR1 polymorphism was shown to be related to the susceptibility for CRC using recessive (OR = 3.76, CI = 2.18–6.51, p < 0.001) and dominant models (OR = 1.96, CI = 1.12–3.45, p = 0.01). No association was found between the variant and Marriage/Education/Smoking/alcohol-consumption status. Our findings demonstrated the association of the genetic variant in the MDR1 gene with susceptibility to CRC, suggesting its potential role as a risk stratification biomarker in CRC patients.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S2452014421002375; http://dx.doi.org/10.1016/j.genrep.2021.101252; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85108559792&origin=inward; https://linkinghub.elsevier.com/retrieve/pii/S2452014421002375; https://dx.doi.org/10.1016/j.genrep.2021.101252
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know